Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast CancersToulsie Ramtohul, A. Tardivon, Louis Redon et al.|Radiology|2023Cited by 122
Initial MRI findings predictive of a pathological complete response to neoadjuvant treatments in HER2-positive breast cancersAnne Ribrag, A. Tardivon, Émilie Lissavalid et al.|European Journal of Radiology|2024Cited by 0